Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

December 19, 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

News Conference News AHA 2017

‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry

November 22, 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

November 02, 2017

Complications During and After PFO Closure, Case #1: Pericardial Effusion

Presentation TCT 2017

Complications During and After PFO Closure, Case #1: Pericardial Effusion

Presenter: John F. Rhodes, Robert J. Sommer, Igor F. Palacios

November 01, 2017

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

October 12, 2017

RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest

News Conference News ACC 2017

RE-CIRCUIT: Doubts Over Dabigatran for A-fib Ablations Put to Rest

Yael L. Maxwell

March 20, 2017

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

News Daily News

Prior Cancer and Chest Radiation Not Associated With Worse PCI Outcomes

February 27, 2017

Early Clinical Outcomes with Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.